Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

PRA Opens Office in Romania

August 22, 2011 6:50 am | by Bio-Medicine.Org | News | Comments

RALEIGH, N.C., Aug. 22, 2011 /PRNewswire/ -- PRA, a leading Clinical Research Organization, recently opened a new office in Bucharest, Romania to further strengthen our coverage of the Balkan region's burgeoning markets. The Bucharest office will also support projects in the neighboring...

Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes ...

August 22, 2011 6:50 am | by Bio-Medicine.Org | News | Comments

FRAZER, Pa., Aug. 22, 2011 /- Cephalon, Inc. (Nasdaq: CEPH ) today provided notice to holders of its 2.50 percent Convertible Senior Subordinated Notes due 2014 (the "2014 Notes") and 2.00 percent Convertible Senior Subordinated Notes due 2015 (the "2015 Notes") in respect of the...

MGT Capital Investments, Inc. Provides Update on Recent Developments

August 22, 2011 6:50 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 22, 2011 /- MGT Capital Investments, Inc. ("MGT", "we", or "the Company") (AMEX: MGT ), a holding company engaged in the medical imaging industry, is providing the following update on recent developments at the Company and its majority-owned subsidiary Medicsight PLC...

Advertisement

Enox Biopharma, Inc. Will Be Granted its Foundation Patent

August 22, 2011 6:50 am | by Bio-Medicine.Org | News | Comments

VANCOUVER, British Columbia, Aug. 22, 2011 /- Enox Biopharma, Inc., a leader in the development of innovative solutions for infections associated with medical devices, today announced that it has received a notice of allowance from the US Patent Office that its patent application entitled...

Etymotic Debuts HD*15 High-Definition Electronic Earplugs for Loud Workplace Environments

August 22, 2011 6:50 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Aug. 22, 2011 /- Etymotic Research , an innovator in hearing wellness solutions, today announced the launch of its HD*15 High-Definition electronic earplugs.  Designed to protect the hearing of anyone who operates around continuous loud noise, HD*15s allow natural hearing...

Etymotic Debuts GunSport*PRO High Definition Electronic Earplugs

August 22, 2011 6:50 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Aug. 22, 2011 /- Etymotic Research , an innovator in hearing wellness solutions, today announced the launch of the GunSport*PRO line of high-definition electronic earplugs.  Designed for gun sport enthusiasts, hunters, guides and professional shooters, the GunSport*PRO...

Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clien...

August 22, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

WEST BEND, Wis., Aug. 22, 2011 /- Clinigene International Limited, an India-based Central and Bioanalytical Laboratory and Phase I-IV Clinical Research Organization, and Spaulding Clinical Research, LLC, US-based leading-edge Clinical Pharmacology, Cardiac Core Lab, and Medical Device...

Cook Medical Remains Resolute in Pursuit of Infringement Action Against Endologix Following Markman Ruling

August 22, 2011 5:46 am | News | Comments

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Incorporated, a global leader in endovascular technologies, announced today that Judge Tanya Walton Pratt of the United States District Court for the Southern District of Indiana...

Advertisement

A Case for Decision Support of Imaging Services

August 22, 2011 5:40 am | by Diagnostic Imaging | News | Comments

While we agree that both approaches can help manage utilization rates of imaging and reduce health care costs, we beg to strongly differ that prior notification is the better option. We have hard facts that indicate decision support is better for not only patients, but providers, health...

Innovative Dialysis Systems, Inc., Announces Opening of Four New Dialysis Facilities in Southern California

August 22, 2011 3:55 am | by Bio-Medicine.Org | News | Comments

LONG BEACH, Calif., Aug. 22, 2011 /- Innovative Dialysis Systems, Inc. announces the opening of four dialysis facilities to provide dialysis patients in and around Los Angeles with more options for high quality nephrology and dialysis care.  These new facilities are located in...

Encision Announces Leadership Change

August 22, 2011 3:55 am | by Bio-Medicine.Org | News | Comments

BOULDER, Colo., Aug. 22, 2011 /- Encision Inc. (Pink Sheets: ECIA ), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, today announced a change in the Company's leadership. Encision has appointed Fred Perner...

Global X-Ray Equipment Market: Strategic Assessments of Leading Suppliers

August 22, 2011 3:55 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 22, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global X-Ray Equipment Market: Strategic Assessments of Leading Suppliers...

Global MRI Market: Strategic Assessments of Leading Suppliers

August 22, 2011 3:55 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 22, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global MRI Market: Strategic Assessments of Leading Suppliers...

Advertisement

I Wanna Be Sublatedâ„¢ Road to Rejuvenationâ„¢ World Tour Prepares to Rock All Ages Through a New Facial Rejuvenation Category.

August 22, 2011 3:55 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 22, 2011 /- Syneron Medical Ltd. (NASDAQ: ELOS ), the global leader in medical aesthetic devices, kicks off the rock of all ages tour with the introduction of The I Wanna Be Sublated, Road to Rejuvenation World Tour – a consumer awareness campaign developed to...

Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System

August 22, 2011 3:52 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 22, 2011 /- Delcath Systems, Inc. (NASDAQ: DCTH ) reported encouraging top-line results from the hepatobiliary cohort of the Phase II clinical trial of the Delcath chemosaturation system with melphalan in the treatment of patients with unresectable liver cancer. This study,...

HeartLightâ„¢ Endoscopic Ablation System Now Available in the UK

August 22, 2011 3:47 am | by Bio-Medicine.Org | News | Comments

MARLBOROUGH, Mass., Aug. 22, 2011 /- CardioFocus, Inc., developer of the HeartLight™ Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that the HeartLight EAS is now available in the United Kingdom. The first AF patients were treated at The...

Sosei to Receive Grant from NEDO's FY2011 Innovation Promotion Programme for Development of Innovative Ophthalmic Solutions

August 22, 2011 12:59 am | by Bio-Medicine.Org | News | Comments

TOKYO, August 22, 2011 /- ? Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), announces that its wholly owned subsidiary Activus Pharma Co., Ltd. ("Activus") is to receive a grant for its "Development of Innovative Ophthalmic Solutions" from the New Energy and Industrial...

First UK Patient Enrolled into Luminous™ Programme – Novartis' 30,000 Patient Observational Study in Ophthalmology

August 21, 2011 11:41 pm | by RealWire | News | Comments

Luminous, launched today, will provide long-term effectiveness, safety, and patient reported outcome data on Lucentis® (ranibizumab) in 30,000 patients in real-life settings across the worldFrimley, August 22 2011 - Novartis Pharmaceuticals UK Ltd (Novartis) has announced the...

3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011

August 19, 2011 9:47 pm | by Bio-Medicine.Org | News | Comments

SHENYANG, China, Aug. 20, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX ) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general...

The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics' Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977

August 19, 2011 5:45 pm | by Bio-Medicine.Org | News | Comments

WHITE PLAINS, N.Y., Aug. 19, 2011 /- Today the Food and Drug Administration (FDA) approved Seattle Genetics' Adcetris to treat two types of rare blood cancers – Hodgkin lymphoma and anaplastic large cell lymphoma (ALCL). (Logo: http://photos.prnewswire.com/prnh/20110215/NY48642LOGO)...

FDA Approves Adcetris to Treat Two Types of Lymphoma

August 19, 2011 5:43 pm | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Aug. 19, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL). (Logo:...

Myths and Realities About Medicare's Competitive Bidding Program for Home Medical Equipment and Services

August 19, 2011 5:43 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON, Aug. 19, 2011 /PRNewswire-USNewswire/ -- As Medicare expands a controversial "competitive" bidding program for home medical equipment and services, economists, consumer groups, and members of Congress have gone on record to oppose that program citing reduced patient access to...

Quanterix forms automated instrument partnership

August 19, 2011 9:54 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Quanterix Corp., a Cambridge-based company that makes an array system for molecular diagnostic tests, said it will move its systems to the next level through a partnership with automated analyzer system company Stratec Biomedical AG of Germany.

CT Coronary Calcium Score Tops CRP as Guide to Therapy

August 19, 2011 9:38 am | by Diagnostic Imaging | News | Comments

Coronary artery calcium (CAC) scores based on cardiac CT scans can stratify the risk of heart disease among those without symptoms, a new study reports.

Summary Information for: Propel?

August 19, 2011 9:31 am | by U.S. Food & Drug Administration | News | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Propel? (P100044).

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading